Stelzer Laurie Insider Trades

Insider Trading History

Track insider trading activity for Stelzer Laurie. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
MBX Biosciences Common Stock
MBX Biosciences Common Stock MBX
Director
Holding Value $580k 12,500 shares
Last Trade
Jun 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$386k 12,500 shares
$30.91
$46.39
PMV Pharmaceuticals
PMV Pharmaceuticals PMVP
Director
Holding Value $50.8k 42,000 shares
Last Trade
Jun 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$50k 42,000 shares
$1.19
$1.21
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $779k 8,026 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$582k 8,026 shares
$72.51
$97.05
MBX Biosciences Common Stock
MBX Biosciences Common Stock MBX
Director
Holding Value $1.48M 32,000 shares
Last Trade
Jan 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.03M 32,000 shares
$32.20
$46.39
PMV Pharmaceuticals
PMV Pharmaceuticals PMVP
Director
Holding Value $40.5k 33,500 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.8k 33,500 shares
$0.95
$1.21
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $2.43M 25,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$389k 25,000 shares
$15.55
$97.05
PMV Pharmaceuticals
PMV Pharmaceuticals PMVP
Director
Holding Value $81.7k 67,500 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$111k 67,500 shares
$1.65
$1.21
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $1.1M 11,323 shares
Last Trade
May 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$445k 11,323 shares
$39.29
$97.05
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Director
Holding Value $601k 50,000 shares
Last Trade
Nov 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$520k 50,000 shares
$10.39
$12.01
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $4.85M 50,000 shares
Last Trade
Nov 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$97.05
Mirati Therapeutics
Mirati Therapeutics MRTX
Chief Financial Officer
Holding Value $6.01M 102,312 shares
Last Trade
Aug 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$825k 22,297 shares
$37.00
$58.70
PMV Pharmaceuticals
PMV Pharmaceuticals PMVP
Director
Holding Value $26k 21,500 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 21,500 shares
$5.59
$1.21
Mirati Therapeutics
Mirati Therapeutics MRTX
Chief Financial Officer
Holding Value $4.7M 80,015 shares
Last Trade
Jun 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$172k 4,647 shares
$37.06
$58.70
Mirati Therapeutics
Mirati Therapeutics MRTX
Director, CFO
Holding Value $4.97M 84,662 shares
Last Trade
Jan 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.3M 72,320 shares
$45.66
$58.70
Surface Oncology
Surface Oncology SURF
Director
Holding Value $25.7k 24,000 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.2k 24,000 shares
$2.01
$1.07
PMV Pharmaceuticals
PMV Pharmaceuticals PMVP
Director
Holding Value $23.6k 19,500 shares
Last Trade
Jun 02, 2022 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$264k 19,500 shares
$13.56
$1.21
Mirati Therapeutics
Mirati Therapeutics MRTX
CFO
Holding Value $5.35M 91,164 shares
Last Trade
Jun 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.95M 148,962 shares
$39.93
$58.70
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
EVP & Chief Financial Officer
Holding Value $2.81M 28,122 shares
Last Trade
Mar 11, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$3.72M 37,208 shares
$99.99
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
EVP & Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 11, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$18.6M 186,050 shares
$99.99
$99.99
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
EVP & Chief Financial Officer
Holding Value $3.64M 36,366 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2M 21,462 shares
$93.19
$99.99

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up